The effects of palonoserton on postoperative nausea and vomiting(PONV) in total knee arthroplasty .

The effects of palonoserton on postoperative nausea and vomiting(PONV) in total knee arthroplasty.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000485

Enrollment

120

Registered

2012-07-18

Start date

2012-02-16

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : We randomly assinged into 2 groups, administering palonosetron0.075mg or no prophylaxis(placebo administration).In patients undergoing both knee arthroplasty, there was one-week interval betwee

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing total knee arthroplasty who understands the study design and voluntarily agrees with the study.

Exclusion criteria

Exclusion criteria: Patients who are contraindicated to spinal anesthesia,did not administered iv-PCA or femoral nerve block, undergoing steroid therapy.

Design outcomes

Primary

Measure	Time frame
postoperative nausea and vomiting(PONV)	—

Secondary

Measure	Time frame
rescue antiemetics	—

Countries

Korea, Republic of

Contacts

Public ContactHye-min Sohn

Seoul National University Bundang Hospital

sophiesohn21@gmail.com+82-31-787-7499

Outcome results